THE Therapeutic Goods Administration (TGA) seeks comments from interested parties on marketing approval for a device, approved in an overseas market, to support its inclusion in the Australian Register of Therapeutic Goods.
Deadline for input is 30 Jun 2017 - see www.tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 May 17
